In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positively influenced by a replacement therapy with plasma derived C1-INH.
CITATION STYLE
Farkas, H., Levy, D., Supina, D., Berger, M., Prusty, S., & Fridman, M. (2020). Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: Findings from a claims database. Allergy, Asthma and Clinical Immunology, 16(1). https://doi.org/10.1186/s13223-020-00439-9
Mendeley helps you to discover research relevant for your work.